2型糖尿病患者的心血管疾病 - Suppr

Suppr

超能文献

Cardiovascular disease in patients with type 2 diabetes.

作者信息

Jeon Ja Young, Kim Dae Jung

机构信息

Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.

出版信息

J Diabetes Investig. 2022 Apr;13(4):614-616. doi: 10.1111/jdi.13742. Epub 2022 Jan 19.

DOI:10.1111/jdi.13742

PMID:34953095

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9017622/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1973/9017622/68b009007857/JDI-13-614-g001.jpg

相似文献

Cardiovascular disease in patients with type 2 diabetes.2型糖尿病患者的心血管疾病

J Diabetes Investig. 2022 Apr;13(4):614-616. doi: 10.1111/jdi.13742. Epub 2022 Jan 19.

Cardiovascular risk factors in Kuwaiti adults with type 2 diabetes.科威特2型糖尿病成年患者的心血管危险因素

Saudi Med J. 2008 Nov;29(11):1669-71.

Cardiovascular risk factors, change in risk factors over 7 years, and the risk of clinical diabetes mellitus type 2. The Tromsø study.心血管危险因素、7年间危险因素的变化以及2型临床糖尿病风险。特罗姆瑟研究。

J Clin Epidemiol. 2002 Jul;55(7):647-53. doi: 10.1016/s0895-4356(02)00404-3.

Cardiovascular disease in diabetes.糖尿病中的心血管疾病

Diabetes Care. 2010 Apr;33(4):e49-54. doi: 10.2337/dc10-zb04.

Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes.饮酒、糖尿病风险以及糖尿病患者的心血管疾病

Curr Diab Rep. 2017 Nov 4;17(12):136. doi: 10.1007/s11892-017-0950-8.

Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer.促性腺激素释放激素激动剂与前列腺癌男性 2 型糖尿病和心血管疾病风险

Drugs. 2011 Feb 12;71(3):255-61. doi: 10.2165/11588930-000000000-00000.

Arguments in favor of screening for diabetes in cardiac rehabilitation.支持在心脏康复中筛查糖尿病的论据。

J Cardiopulm Rehabil. 1995 Mar-Apr;15(2):97-102. doi: 10.1097/00008483-199503000-00001.

Diabetes medications improve cardiovascular outcomes: the paradigm shifts.糖尿病药物改善心血管结局：范式转变。

Curr Opin Lipidol. 2016 Dec;27(6):633-635. doi: 10.1097/MOL.0000000000000361.

[Management of diabetes in cardiac diseases].[心脏病中的糖尿病管理]

Anadolu Kardiyol Derg. 2009 Jun;9(3):238-47.

Reducing the modifiable risks of cardiovascular disease in Turkish patients with type 2 diabetes: the effectiveness of training.降低土耳其2型糖尿病患者心血管疾病的可改变风险：培训的效果

Clin Nurs Res. 2015 Jun;24(3):299-317. doi: 10.1177/1054773814531288. Epub 2014 Apr 29.

本文引用的文献

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs.GLP-1 受体激动剂与 2 型糖尿病的心脏肾脏结局：八项心血管结局试验的更新荟萃分析。

Cardiovasc Diabetol. 2021 Sep 15;20(1):189. doi: 10.1186/s12933-021-01366-8.

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.SGLT2 抑制剂和 GLP-1 受体激动剂：已确立和新兴的适应证。

Lancet. 2021 Jul 17;398(10296):262-276. doi: 10.1016/S0140-6736(21)00536-5. Epub 2021 Jun 30.

Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.在日本 2 型糖尿病高危患者中，血糖波动幅度与心血管疾病风险的相关性：EMPATHY 试验的一项亚组分析。

J Diabetes Investig. 2021 Dec;12(12):2190-2196. doi: 10.1111/jdi.13597. Epub 2021 Jun 25.

Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database.日本老年糖尿病患者血糖控制与心血管事件的关系：日本医疗管理数据库分析。

J Diabetes Investig. 2021 Nov;12(11):2036-2045. doi: 10.1111/jdi.13575. Epub 2021 Jun 6.

Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A nationwide study.根据最近诊断的糖尿病和胰岛素治疗的需求评估早期死亡率和心血管疾病风险：一项全国性研究。

J Diabetes Investig. 2021 Oct;12(10):1855-1863. doi: 10.1111/jdi.13539. Epub 2021 Mar 18.

10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理：。

Diabetes Care. 2021 Jan;44(Suppl 1):S125-S150. doi: 10.2337/dc21-S010.

Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea.韩国糖尿病患者心血管并发症和死亡率的趋势。

Diabetes Metab J. 2021 Jan;45(1):120-124. doi: 10.4093/dmj.2020.0175. Epub 2020 Dec 9.

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population.患有 2 型糖尿病与不患有 2 型糖尿病的人群中心血管事件和死亡率：当代多民族人群中的一项观察性研究。

J Diabetes Investig. 2021 Jul;12(7):1175-1182. doi: 10.1111/jdi.13464. Epub 2020 Dec 15.

New prospects for incretin-related drugs in the treatment of type 2 diabetes.肠促胰岛素相关药物在 2 型糖尿病治疗中的新前景。

J Diabetes Investig. 2021 Jul;12(7):1141-1143. doi: 10.1111/jdi.13460. Epub 2020 Dec 9.

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus.钠-葡萄糖共转运蛋白 2 抑制剂作为 2 型糖尿病患者二甲双胍单药治疗的附加药物的心血管安全性。

Diabetes Metab J. 2021 Jul;45(4):505-514. doi: 10.4093/dmj.2020.0057. Epub 2020 Oct 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验